CytomX Therapeutics (CTMX) Tops Q1 EPS by 2c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| Eaton Vance Dividend Builder Fd Cl C (NASDAQ: CTMX) | Delayed: 2.23 -0.11 (4.7%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.34 | 52 Week High | $24.68 | |||
| Open | $2.36 | 52 Week Low | $9.10 | |||
| Day High | $2.39 | P/E | N/A | |||
| Day Low | $2.14 | EPS | $0.00 | |||
| Volume | 9,469,882 | |||||
